Lateral Flow Assays Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Lateral Flow Readers), By Application (Clinical Testing, Veterinary Diagnostics), By Technique (Sandwich, Competitive), By End-use, By Region, And Segment Forecas

Lateral Flow Assays Market Summary

The global lateral flow assays (LFA) market size was estimated at approximately USD 10.17 billion in 2025 and is projected to reach USD 17.44 billion by 2033, growing at a CAGR of 7.41% from 2026 to 2033, driven by the increasing demand for rapid and cost-effective diagnostic solutions, particularly in Point-of-Care (POC) and home-testing applications. Infectious diseases remain one of the main global health challenges.

Infectious diseases remain one of the main global health challenges. In 2025, new infectious disease threats have emerged, further underscoring the need for LFAs. In Louisiana, a fatal case of avian influenza A (H5N1) was reported, linked to inadequate protective equipment among workers handling infected animals. The CDC noted 67 human cases of H5N1 in 2024, with 40 cases tied to dairy cattle exposure and 23 to poultry farms. The UK responded by securing 5 million doses of an H5 vaccine to mitigate risks in 2025. In February 2025, Ireland confirmed its first case of mpox caused by monkeypox clade I, a strain previously dominant in Africa. Simultaneously, Uganda declared an Ebola outbreak in January 2025, with the WHO confirming seven cases, including one fatality, by February. These outbreaks illustrate the unpredictable nature of infectious diseases, driven by global interconnectivity and environmental factors.

The high prevalence of infectious diseases worldwide has been a major driver for the market growth. These diseases necessitate novel diagnostic techniques for efficient treatment to stop the rising mortality rate. The COVID-19 pandemic, in particular, highlighted the need for rapid and accessible diagnostic tools, leading to a surge in demand for LFAs. Beyond COVID-19, other infectious threats have emerged. For instance, in 2025, a highly pathogenic avian influenza A (H5N1) virus infection resulted in a fatality in Louisiana, USA, despite the use of personal protective equipment that was deemed inadequate. According to the Centers for Disease Control and Prevention (CDC), while the general public faces a low risk, individuals working closely with infected animals-such as farmers, veterinarians, and wildlife facility staff-remain highly vulnerable. In 2024, 67 human cases of avian influenza were reported, with 40 linked to exposure to dairy cattle and 23 associated with poultry farms. In response, the UK proactively secured 5 million doses of the H5 vaccine to mitigate potential risks in 2025.

Technological advancements now allow for improved performance and use of lateral flow assays, including advances in sensitivity, specificity, multiplexing, and digital applications via smartphone apps and cloud-connected devices. The latter advances have meant that lateral flow devices may be used in areas outside infectious disease detection, including pregnancy testing, heart disease monitoring, veterinary diagnostics, environmental testing, and food safety. As part of the advances above, Abingdon Health plc (UK) has established itself as a key player in the lateral flow market. In May 2024, Abingdon Health plc launched Boots' own-brand saliva-based pregnancy self-test to the UK and online via Salignostics and Crest Medical. This product represents a technological shift from traditional urine-based pregnancy tests to non-invasive saliva testing, thus providing greater convenience and accessibility for the user. In addition to launching the product, the significant advancement in product innovation provided an opportunity to further strengthen Abingdon Health's strategic partnership with Boots as the first company to adapt a saliva pregnancy self-test into Boots' own-brand range. These advances demonstrate how biotechnology innovation, consumer health, and strategic partnerships continue to influence the direction of the global lateral flow assays industry.

Global Lateral Flow Assays Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global lateral flow assays market report based on product, application, technique, end-use, and region:

• Product Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
• Kits & Reagents
• Lateral Flow Readers
• Digital/Mobile Readers
• Benchtop Readers
• Application Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
• Clinical Testing
• Infectious Diseases Testing
• COVID-19 Testing
• Mosquito Borne Disease Testing
• Malaria Testing
• Dengue Testing
• Zika Testing
• Chikungunya Testing
• Others
• Influenza Testing
• Sexually Transmitted Infection Testing
• HIV Testing
• HPV Testing
• Chlamydia Testing
• Gonorrhea Testing
• Syphilis Testing
• Others
• Hepatitis
• Tuberculosis
• Others
• Cardiac Marker Testing
• Troponin I and T Testing
• CK-MB Testing
• BNP and NT-proBNP Testing
• Myoglobin Testing
• D-Dimer Testing
• Others
• Pregnancy & Fertility Testing
• Pregnancy Testing
• Fertility Testing
• Cholesterol Testing/Lipid Profile Testing
• Drugs of Abuse Testing
• Others
• Veterinary Diagnostics
• Food safety & Environment Testing
• Drug Development & Quality Testing
• Technique Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
• Sandwich Assays
• Competitive Assays
• Multiplex Detection Assays
• End-use Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care
• Pharmaceutical & Biotechnology Companies
• Others
• Regional Outlook (Volume, Thousands; Revenue, USD Million, 2021 - 2033)
• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Sweden
• Denmark
• Norway
• Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

Please note The report will be delivered in 2-3 business days upon order notification. Show more